-transparent.png){kind=logo}
Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder. 2010
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
University of Tampere, Medical School, Tampere, Finland. ari.illi@uta.fi
The functional val108/158met polymorphism of the COMT gene (rs4680) was evaluated in major depressive disorder (MDD), and in the treatment response to antidepressants in MDD. We could not demonstrate any significant difference in the distribution of this COMT single-nucleotide polymorphism (SNP) in the treatment response to selective serotonin reuptake inhibitors or between patients with MDD and control subjects.
Related Publications
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
June 2007,
Human psychopharmacology,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
November 2004,
Biological psychiatry,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
February 2012,
The pharmacogenomics journal,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
January 2005,
Neuropsychobiology,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
January 2009,
PloS one,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
September 2015,
Psychiatry research,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
March 2018,
Sleep,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
January 2005,
The pharmacogenomics journal,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
March 2017,
Molecular neurobiology,
Ari Illi, and
Eija Setälä-Soikkeli, and
Olli Kampman, and
Merja Viikki, and
Timo Nuolivirta, and
Outi Poutanen, and
Heini Huhtala, and
Nina Mononen, and
Terho Lehtimäki, and
Esa Leinonen
March 2024,
Journal of affective disorders,
